Medical Equipment Quarterly Deals Analysis M&A and Investment Trends – Q2 2017

Price :
Published : Sep-2017
No. of Pages : 85

Medical Equipment Quarterly Deals Analysis M&A and Investment Trends – Q2 2017


GlobalData’s “Medical Equipment Quarterly Deals Analysis M&A and Investment Trends – Q2 2017”, report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the medical equipment industry in Q2 2017. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, segments and geographies. Additionally, the report provides information on the top financial advisory firms in the medical equipment industry.

Data presented in this report is derived from GlobalData’s proprietary in-house Medical Equipment eTrack deals database and primary and secondary research.

The medical equipment sector recorded an increase in the number of deals and deal values in Q2 2017 with 753 deals worth USD90.3 billion, as compared to 700 deals worth USD55.5 billion in Q2 2016. On quarter-on-quarter basis, the number of deals and deal values increased in Q2 2017, when compared with 642 deals worth USD73.8 billion in Q1 2017. The in vitro diagnostics market recorded the highest number of deals. In Q2 2017, the market recorded 230 deals, followed by healthcare IT market with 147 deals. In Q2 2017, North America recorded 494 deals, as compared to 419 deals in Q1 2017. Mergers and acquisitions (M&As), including asset transactions, recorded an increase in the number of deals and deal values in Q2 2017 with 120 deals worth USD51.3 billion, as compared to 104 deals worth USD33.4 billion in Q2 2016. On quarter-on-quarter basis, the number of deals and deal values increased in Q2 2017, when compared to 88 deals worth USD46.9 billion in Q1 2017.

– Analyze market trends for the medical equipment/medical devices market in the global arena
– Review of deal trends in anesthesia and respiratory devices, cardiovascular devices, dental devices, diabetes care devices, diagnostic imaging, drug delivery devices, endoscopy devices, ENT devices, healthcare IT, hospital supplies, in vitro diagnostics, nephrology and urology devices, neurology devices, opthalmic devices, patient monitoring, surgical equipment, and wound care management segments
– Analysis of M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships in the medical equipment market
– Summary of medical equipment deals globally in the last five quarters
– Information on the top deals that took place in the medical equipment market
– Geographies covered include – North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa
– League Tables of financial advisors in M&A and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs
– Review the financial metrics, such as operating profit ratio, P/E ratio, and EV/EBITDA on mergers and acquisitions

Reasons to buy
– Enhance your decision making capability in a more rapid and time sensitive manner.
– Find out the major deal performing segments for investments in your industry.
– Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
– Identify companies that are aggressively looking to raise capital in the market
– Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
– Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
– Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
– Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
– Identify growth segments and opportunities in each region within the industry.
– Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

Filed in: Medical Device
Publisher : GlobalData
More Reports
Title Price Buy Now

Ablation Equipments – Medical Devices Pipeline Assessment, 2017

Ablation Equipments - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, "Ablation Equipments - Medical Devices Pipeline Assessment, 2017" provides an overview of Ablation Equipments currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ablation Equipments pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary researc......

Smiths Group Plc (SMIN) – Medical Equipment – Deals and Alliances Profile

Summary Smiths Group plc (Smiths Group) is a technology company. It offers products and services for threat and contraband detection, medical devices, energy, and communications industries through five business divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The company also sells disposable consumables and offers after-sales services to its customers. Smiths Group's customer base includes various governmental agencies, hospitals, petrochemical companies, contractors, equipment manufacturers, service providers, aerospace engine and airframe manufacturers, domestic appliance manufacturers, and the US construction industry. The company has manufacturing and service facilities in several countries in Americas, Europe and Asia-Pacific. Smiths Group i......

Syncardia Systems LLC – Medical Equipment – Deals and Alliances Profile

Summary Syncardia Systems LLC (SynCardia), a subsidiary of Versa Capital Management, Inc. develops and manufactures artificial human heart. Its flagship product, SynCardia temporary Total Artificial Heart (TAH-t) temporarily takes up the complete function of a failed human heart in patients suffering from final stage biventricular heart failure (BHF) before receiving a successful heart transplant. The TAH-t replaces the ventricles and four heart valves of a failing heart and eliminates the symptoms and source of end-stage BHF. SynCardia also offers the Freedom portable external pneumatic drivers, which power TAH-t and facilitate the discharge of clinically stable patients from the hospital, while waiting for a matching donor heart. The company offers TAH-t through certified centers in var......

W. L. Gore & Associates Inc – Medical Equipment – Deals and Alliances Profile

Summary W. L. Gore & Associates Inc (Gore) is a manufacturer and distributor of fluoropolymer products. Its product portfolio includes consumer products, cables, electronic components, fabrics, fibers, medical, pharmaceutical, sealing and vents. The company has developed numerous products for medical implants; fabric laminates; and cable, filtration, membrane, venting, fiber technologies, and sealant for diverse industries through its proprietary technologies with the polymer polytetrafluoroethylene (PTFE). Gore caters to aerospace, automotive, chemical processing, computer, telecommunications, electronics, energy, environmental, industrial, manufacturing, military, and pharmaceutical, biotechnology, and textile markets. The company has manufacturing facilities in the US, Germany, the UK,......

Vectura Group Plc (VEC) – Medical Equipment – Deals and Alliances Profile

Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary fibrosis and other diseases. The company develops products based on a wide range of proprietary lung delivery technologies, including device and formulation capabilities. Vectura has a varied portfolio of drugs in clinical development, comprising several novel and generic programs that are partnered with several global biotechnology and pharmaceutical companies. Vectura is headquartered in Chippenham, Wiltshire, the UK. Vectura Group Plc (VEC) - Medical Equipment -......

Tecan Group Ltd (TECN) – Medical Equipment – Deals and Alliances Profile

Summary Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation suppliers. Its product portfolio encompasses liquid handling and robotics, reader and washer, microarray products, components, software, and consumables. Tecan's products find applications in agriculture, forensic solutions, analytical chemistry, cell biology, drug discovery, genomic solutions, protein science solutions, ELISA solutions and synthetic biology. The company has manufacturing facilities, and research and development facilities in Europe and North America. Tecan is headquartered in Man......

Varian Medical Systems Inc (VAR) – Medical Equipment – Deals and Alliances Profile

Summary Varian Medical Systems Inc (Varian) designs, manufactures and sells equipment and software for the diagnosis and treatment of cancer and other medical conditions through radiotherapy, radiosurgery, proton therapy and brachytherapy. Its major products include brachytherapy afterloaders, linear accelerators, treatment simulation and verification equipment, X-ray tubes, high voltage connectors, and flat panel digital image detectors. Varian also offers software solutions for information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support and practice management. The company's products find application in fluoroscopic imaging, mammography, computed tomography, cargo scanning, computer-aided diagnostics and oth......

SurModics Inc (SRDX) – Medical Equipment – Deals and Alliances Profile

Summary SurModics Inc (SurModics) is a provider of device drug delivery coating and in vitro diagnostic technologies. The company offers wide range of advanced technologies that includes medical device coating technologies and surface modification coating technologies. Its technologies are employed in the development of new medical devices, biomedical products and in the enhancement of existing products and devices. SurModics commercializes its technologies through licensing and royalty arrangements with medical device manufacturers. SurModics sells components for in vitro diagnostic test kits and microarrays; and manufactures and distributes surface coatings to the diagnostic and biomedical research markets. The company has a wide distribution network across the world. SurModics is headq......

Verisante Technology Inc (VRS) – Medical Equipment – Deals and Alliances Profile

Summary Verisante Technology Inc (Verisante), develops and commercializes products for the early detection of all forms of skin cancer. The company's key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Verisante Core is used for lung, colon and cervical cancer detection. Verisante MSI Camera is a multispectral imaging camera used in the detection of oral and skin cancer. The cancer detection technology helps the company to develop and offer wide range of compact and non-invasive cancer detection devices. The company is ISO 13485:2003 certified as a medical device manufacturer. Verisante is headquartered in Richmond, British Columbia, Canada. Verisante Technology Inc (VRS) - Medical Equipment - De......

TBG Diagnostics Ltd (TDL) – Medical Equipment – Deals and Alliances Profile

Summary TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is molecular diagnostics company that researches, develops, manufactures and markets molecular diagnostics kits, instruments and services. Its products are used in a wide range of applications such as medical research, clinical trials and drug discovery and diagnostic laboratories in hospitals. The company offers its products and services to clients in clinical laboratories of hospitals and independent reference labs, blood centers and bone marrow registry labs. It operates research and development (R&D) facilities in the US, Taiwan and China and a manufacturing facility in Xiamen, China. TBG Diagnostics is headquartered in Greenslopes, Queensland, Australia. TBG Diagnostics Ltd (TDL) - Medical Equipment ......